FLUARIX Research Report 2023: A Vaccine Indicated for Active Immunization to Prevent Disease Caused by Influenza A Subtype Viruses and Type B Viruses - Drug Insights and Market Forecasts 2019-2032
December 12, 2023 05:13 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...